Patient's Perspective on the Impact of COVID-19 on Cancer Treatment in Nigeria
PURPOSEBecause of the global COVID-19 pandemic, health care organizations introduced guidelines for modifications to health and cancer medical care delivery to mitigate transmission and ensure quality health outcomes. To examine the extent and impact of these modifications on oncology service disrup...
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society of Clinical Oncology
2022-03-01
|
| Series: | JCO Global Oncology |
| Online Access: | https://ascopubs.org/doi/10.1200/GO.21.00244 |
| _version_ | 1828880053649276928 |
|---|---|
| author | Adedayo Joseph Bankole Olatosi Mohammad Rifat Haider Bolanle C. Adegboyega Nwamaka N. Lasebikan Usman M. Aliyu Musa Ali-Gombe Mutiu A. Jimoh Olusegun Abayomi Biyi-Olutunde Opeyemi Awofeso Omolara Aminat Fatiregun Evaristus Oseiwe Oboh Emmanuella Nwachukwu Ismail H. Zubairu Samuel A. Otene Oluwatoyin I. Iyare Temitope Andero Alabi Babatunde Musbau Azeezat Ajose Adedayo A. Onitilo |
| author_facet | Adedayo Joseph Bankole Olatosi Mohammad Rifat Haider Bolanle C. Adegboyega Nwamaka N. Lasebikan Usman M. Aliyu Musa Ali-Gombe Mutiu A. Jimoh Olusegun Abayomi Biyi-Olutunde Opeyemi Awofeso Omolara Aminat Fatiregun Evaristus Oseiwe Oboh Emmanuella Nwachukwu Ismail H. Zubairu Samuel A. Otene Oluwatoyin I. Iyare Temitope Andero Alabi Babatunde Musbau Azeezat Ajose Adedayo A. Onitilo |
| author_sort | Adedayo Joseph |
| collection | DOAJ |
| description | PURPOSEBecause of the global COVID-19 pandemic, health care organizations introduced guidelines for modifications to health and cancer medical care delivery to mitigate transmission and ensure quality health outcomes. To examine the extent and impact of these modifications on oncology service disruptions in Nigeria, we surveyed oncology patients across selected public and private cancer treatment centers.MATERIALS AND METHODSParticipating in the study were 15 tertiary cancer treatment centers across 12 Nigerian states. We recruited adult patients with cancer (18+ years) on active treatment to complete a self-administered survey on cancer care during COVID-19. We conducted descriptive and multivariate data analysis using Stata 16.1.RESULTSRespondents were (n = 1,072), female (65.7%), ages 18-49 years (50.3%), and married (80.7%). The top two cancers were breast and prostate. Overall, 17.3% of respondents reported disruptions to cancer care, and more than half (51.0%) reported difficulties accessing care. Changes in chemotherapy regimens or route of administration were reported in 8.4% of respondents. Odds for any disruption were highest for older patients, western states, patients with prostate cancer, and patients with two or more flu symptoms. Odds for radiotherapy cancellation were highest for older patients, those with prostate cancer, and those with medium service perception.CONCLUSIONThis study investigated COVID-19–influenced cancer treatment disruptions in Nigeria. Patients with cancer experienced significant disruptions to cancer care. Vulnerable patients are most likely to be negatively affected. Policies and strategies aimed at minimizing service disruptions while maintaining cancer patients' safety should be a priority for all health care institutions in the COVID-19 era. |
| first_indexed | 2024-12-13T09:40:16Z |
| format | Article |
| id | doaj.art-292869facd884279bf1a07a2a0f8d784 |
| institution | Directory Open Access Journal |
| issn | 2687-8941 |
| language | English |
| last_indexed | 2024-12-13T09:40:16Z |
| publishDate | 2022-03-01 |
| publisher | American Society of Clinical Oncology |
| record_format | Article |
| series | JCO Global Oncology |
| spelling | doaj.art-292869facd884279bf1a07a2a0f8d7842022-12-21T23:52:13ZengAmerican Society of Clinical OncologyJCO Global Oncology2687-89412022-03-01810.1200/GO.21.00244Patient's Perspective on the Impact of COVID-19 on Cancer Treatment in NigeriaAdedayo Joseph0Bankole Olatosi1Mohammad Rifat Haider2Bolanle C. Adegboyega3Nwamaka N. Lasebikan4Usman M. Aliyu5Musa Ali-Gombe6Mutiu A. Jimoh7Olusegun Abayomi Biyi-Olutunde8Opeyemi Awofeso9Omolara Aminat Fatiregun10Evaristus Oseiwe Oboh11Emmanuella Nwachukwu12Ismail H. Zubairu13Samuel A. Otene14Oluwatoyin I. Iyare15Temitope Andero16Alabi Babatunde Musbau17Azeezat Ajose18Adedayo A. Onitilo19NSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Lagos, NigeriaHealth Services, Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia, SCDepartment of Health Policy and Management, College of Public Health, University of Georgia, Athens, GANSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Lagos, NigeriaUniversity of Nigeria Teaching Hospital, Enugu, NigeriaUsman Danfodiyo University Teaching Hospital, Sokoto, NigeriaFederal Teaching Hospital, Gombe, NigeriaUniversity College Hospital, Ibadan, Oyo, NigeriaUniversity of Port-Harcourt Teaching Hospital, Port-Harcourt, Rivers State, NigeriaLagos University Teaching Hospital, Idiaraba, Lagos, NigeriaDepartment of Radiology, Lagos State University Teaching Hospital (LASUTH), Lagos, NigeriaUniversity of Benin Teaching Hospital, Edo, NigeriaNational Hospital, Abuja, Federal Capital Territory, NigeriaAhmadu Bello University Teaching Hospital, Kaduna, NigeriaFederal Medical Centre, Makurdi, Borno, NigeriaAlex Ekwueme Federal Teaching Hospital Abakaliki, Ebonyi, NigeriaEko Hospital, Lagos, NigeriaFederal Medical Centre, Abeokuta, Ogun, NigeriaLagos University Teaching Hospital, Idiaraba, Lagos, NigeriaDepartment of Oncology, Marshfield Clinic Health System, Marshfield, WIPURPOSEBecause of the global COVID-19 pandemic, health care organizations introduced guidelines for modifications to health and cancer medical care delivery to mitigate transmission and ensure quality health outcomes. To examine the extent and impact of these modifications on oncology service disruptions in Nigeria, we surveyed oncology patients across selected public and private cancer treatment centers.MATERIALS AND METHODSParticipating in the study were 15 tertiary cancer treatment centers across 12 Nigerian states. We recruited adult patients with cancer (18+ years) on active treatment to complete a self-administered survey on cancer care during COVID-19. We conducted descriptive and multivariate data analysis using Stata 16.1.RESULTSRespondents were (n = 1,072), female (65.7%), ages 18-49 years (50.3%), and married (80.7%). The top two cancers were breast and prostate. Overall, 17.3% of respondents reported disruptions to cancer care, and more than half (51.0%) reported difficulties accessing care. Changes in chemotherapy regimens or route of administration were reported in 8.4% of respondents. Odds for any disruption were highest for older patients, western states, patients with prostate cancer, and patients with two or more flu symptoms. Odds for radiotherapy cancellation were highest for older patients, those with prostate cancer, and those with medium service perception.CONCLUSIONThis study investigated COVID-19–influenced cancer treatment disruptions in Nigeria. Patients with cancer experienced significant disruptions to cancer care. Vulnerable patients are most likely to be negatively affected. Policies and strategies aimed at minimizing service disruptions while maintaining cancer patients' safety should be a priority for all health care institutions in the COVID-19 era.https://ascopubs.org/doi/10.1200/GO.21.00244 |
| spellingShingle | Adedayo Joseph Bankole Olatosi Mohammad Rifat Haider Bolanle C. Adegboyega Nwamaka N. Lasebikan Usman M. Aliyu Musa Ali-Gombe Mutiu A. Jimoh Olusegun Abayomi Biyi-Olutunde Opeyemi Awofeso Omolara Aminat Fatiregun Evaristus Oseiwe Oboh Emmanuella Nwachukwu Ismail H. Zubairu Samuel A. Otene Oluwatoyin I. Iyare Temitope Andero Alabi Babatunde Musbau Azeezat Ajose Adedayo A. Onitilo Patient's Perspective on the Impact of COVID-19 on Cancer Treatment in Nigeria JCO Global Oncology |
| title | Patient's Perspective on the Impact of COVID-19 on Cancer Treatment in Nigeria |
| title_full | Patient's Perspective on the Impact of COVID-19 on Cancer Treatment in Nigeria |
| title_fullStr | Patient's Perspective on the Impact of COVID-19 on Cancer Treatment in Nigeria |
| title_full_unstemmed | Patient's Perspective on the Impact of COVID-19 on Cancer Treatment in Nigeria |
| title_short | Patient's Perspective on the Impact of COVID-19 on Cancer Treatment in Nigeria |
| title_sort | patient s perspective on the impact of covid 19 on cancer treatment in nigeria |
| url | https://ascopubs.org/doi/10.1200/GO.21.00244 |
| work_keys_str_mv | AT adedayojoseph patientsperspectiveontheimpactofcovid19oncancertreatmentinnigeria AT bankoleolatosi patientsperspectiveontheimpactofcovid19oncancertreatmentinnigeria AT mohammadrifathaider patientsperspectiveontheimpactofcovid19oncancertreatmentinnigeria AT bolanlecadegboyega patientsperspectiveontheimpactofcovid19oncancertreatmentinnigeria AT nwamakanlasebikan patientsperspectiveontheimpactofcovid19oncancertreatmentinnigeria AT usmanmaliyu patientsperspectiveontheimpactofcovid19oncancertreatmentinnigeria AT musaaligombe patientsperspectiveontheimpactofcovid19oncancertreatmentinnigeria AT mutiuajimoh patientsperspectiveontheimpactofcovid19oncancertreatmentinnigeria AT olusegunabayomibiyiolutunde patientsperspectiveontheimpactofcovid19oncancertreatmentinnigeria AT opeyemiawofeso patientsperspectiveontheimpactofcovid19oncancertreatmentinnigeria AT omolaraaminatfatiregun patientsperspectiveontheimpactofcovid19oncancertreatmentinnigeria AT evaristusoseiweoboh patientsperspectiveontheimpactofcovid19oncancertreatmentinnigeria AT emmanuellanwachukwu patientsperspectiveontheimpactofcovid19oncancertreatmentinnigeria AT ismailhzubairu patientsperspectiveontheimpactofcovid19oncancertreatmentinnigeria AT samuelaotene patientsperspectiveontheimpactofcovid19oncancertreatmentinnigeria AT oluwatoyiniiyare patientsperspectiveontheimpactofcovid19oncancertreatmentinnigeria AT temitopeandero patientsperspectiveontheimpactofcovid19oncancertreatmentinnigeria AT alabibabatundemusbau patientsperspectiveontheimpactofcovid19oncancertreatmentinnigeria AT azeezatajose patientsperspectiveontheimpactofcovid19oncancertreatmentinnigeria AT adedayoaonitilo patientsperspectiveontheimpactofcovid19oncancertreatmentinnigeria |